Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-05 Sale |
2022-01-07 6:06 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
5,007 | $44.78 | $224,213 | 2,312,052 (Indirect Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 6:06 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
2,225 | $44.75 | $99,569 | 974,077 (Indirect Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 6:05 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,845 | $44.78 | $127,399 | 288,101 (Indirect Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 6:05 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
2,846 | $44.77 | $127,415 | 567,691 (Indirect Direct) |
View |
| 2021-12-28 Sale |
2021-12-30 9:59 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
63,131 | $44.43 | $2,805,197 | 2,323,218 (Indirect Direct) |
View |
| 2021-12-06 Sale |
2021-12-08 5:35 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $42.27 | $422,736 | 539,537 (Indirect Direct) |
View |
| 2021-12-06 Sale |
2021-12-08 5:35 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,476 | $42.52 | $62,760 | 259,946 (Indirect Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 4:23 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,333 | $44.92 | $823,581 | 2,255,059 (Indirect Direct) |
View |
| 2021-11-10 Sale |
2021-11-12 4:31 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $52.81 | $87,983 | 126,167 (Direct) |
View |
| 2021-11-04 Sale |
2021-11-08 4:16 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $52.84 | $528,404 | 549,537 (Indirect Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 5:32 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,333 | $49.76 | $912,176 | 2,273,392 (Indirect Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 5:30 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $50.05 | $83,383 | 127,833 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-06 6:14 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $50.56 | $505,605 | 559,537 (Indirect Direct) |
View |
| 2021-10-01 Sale |
2021-10-05 4:27 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,333 | $50.38 | $923,550 | 2,291,725 (Indirect Direct) |
View |
| 2021-09-15 Sale |
2021-09-17 4:04 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $53.4 | $88,969 | 129,499 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-09 5:08 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $55.55 | $555,485 | 560,492 (Indirect Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 06:53 am |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,333 | $54.66 | $1,002,012 | 2,310,058 (Indirect Direct) |
View |
| 2021-08-23 Sale |
2021-08-25 6:26 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
6,143 | $48.91 | $300,454 | 261,422 (Indirect Direct) |
View |
| 2021-08-19 Sale |
2021-08-23 8:25 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,546 | $49.58 | $126,230 | 267,565 (Indirect Direct) |
View |
| 2021-08-19 Sale |
2021-08-23 8:25 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
2,544 | $49.6 | $126,186 | 570,492 (Indirect Direct) |
View |
| 2021-08-19 Sale |
2021-08-23 8:25 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
2,376 | $49.57 | $117,769 | 2,328,391 (Indirect Direct) |
View |
| 2021-08-19 Sale |
2021-08-23 8:24 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
2,285 | $49.57 | $113,263 | 945,302 (Indirect Direct) |
View |
| 2021-08-18 Sale |
2021-08-20 5:29 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $51.7 | $86,139 | 131,165 (Direct) |
View |
| 2021-08-04 Sale |
2021-08-06 4:09 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $52.22 | $522,233 | 573,036 (Indirect Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 7:14 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,333 | $51.41 | $942,477 | 2,330,767 (Indirect Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 5:33 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $65.13 | $108,510 | 132,831 (Direct) |
View |
| 2021-07-06 Sale |
2021-07-08 4:06 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $76.2 | $762,040 | 583,036 (Indirect Direct) |
View |
| 2021-07-01 Sale |
2021-07-06 4:14 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,333 | $77.25 | $1,416,300 | 2,349,100 (Indirect Direct) |
View |
| 2021-06-23 Sale |
2021-06-24 4:51 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $70.74 | $117,845 | 134,497 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-08 5:10 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
94,378 | $70.35 | $6,639,523 | 2,552,232 (Direct) |
View |
| 2021-06-04 Sale |
2021-06-08 5:10 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $64.55 | $645,500 | 593,036 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-03 Option Award |
2022-01-05 7:04 pm |
N/A 2032-01-02 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
124,000 | $0 | 663,537 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:03 pm |
N/A 2032-01-02 |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
124,000 | $0 | 383,946 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:03 pm |
N/A 2032-01-02 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
248,500 | $0 | 2,503,559 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:03 pm |
N/A 2032-01-02 |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
124,000 | $0 | 1,069,302 (Direct) |
View |
| 2021-10-04 Gift |
2021-12-30 9:59 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
400,000 | $0 | 2,323,218 (Direct) |
View |
| 2021-09-20 Exercise |
2021-09-22 6:06 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
9,045 | $0 | 809,615 (Direct) |
View |
| 2021-09-20 Exercise |
2021-09-22 6:06 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
9,045 | $0.68 | 809,615 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 5:10 pm |
N/A 2027-12-07 |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
94,378 | $0 | 2,552,232 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 5:10 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
27,245 | $19.5 | 2,552,232 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 5:10 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
39,303 | $18 | 2,552,232 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 5:10 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
27,830 | $18.92 | 2,552,232 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 6:37 pm |
N/A 2031-06-02 |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
8,296 | $0 | 2,550,592 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 6:37 pm |
N/A 2031-06-02 |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
8,296 | $0 | 69,013 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 6:36 pm |
N/A 2031-06-02 |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
8,296 | $0 | 142,385 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 6:35 pm |
N/A 2031-06-02 |
Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director |
8,296 | $0 | 9,687,403 (Direct) |
View |